Tumour necrosis factor α (TNF-α) regulates the transport of myo-inositol in 3T3-L1 adipocytes. Treating 3T3-L1 adipocytes with TNF-α decreases Na + \myo-inositol co-transporter (SMIT) mRNA levels and myo-inositol accumulation in a concentrationand time-dependent manner. TNF-α decreases the V max for high-affinity myo-inositol transport with little change in the K m . Studies with actinomycin D suggest that RNA synthesis is required for the TNF-α-induced effect on SMIT mRNA levels. In contrast with the effect of TNF-α, hyperosmolarity increases SMIT mRNA levels and myo-inositol accumulation in 3T3-L1 adipocytes. Hyperosmolarity increases SMIT gene expression as evidenced by the inhibition of hyperosmotic induction of SMIT mRNA levels by actinomycin D, and of myo-inositol accumulation by actinomycin D and cycloheximide. TNF-α and osmotic stress have previously been shown to activate similar signal transduction pathways in mammalian cells. In 3T3-L1 adipocytes, both TNF-α and hyperosmolarity increase mitogen-
INTRODUCTION
We have previously reported that tumour necrosis factor α (TNF-α) selectively decreases levels of Na + \myo-inositol cotransporter (SMIT) mRNA and myo-inositol accumulation in cultured large vessel and cerebral microvessel endothelial cells [1] . In contrast, TNF-α did not affect myo-inositol accumulation by a variety of other cultured mammalian cells [1] , although an effect of TNF-α on SMIT mRNA levels and myo-inositol accumulation was observed in adipocytes. To explore further the effect of TNF-α on myo-inositol metabolism, we chose to study 3T3-L1 adipocytes. As in endothelial cells, TNF-α has a wide range of effects on adipocytes and has been linked to the development of insulin resistance [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] .
TNF-α is synthesized and secreted from adipose tissue and acts in an autocrine-like fashion to mediate a wide range of biological effects [6] [7] [8] [9] [10] [11] [12] . Overexpression of TNF-α mRNA and increased production of TNF-α by adipose tissue have been described in many animal models of insulin resistance and obesity [11, 13, 14] . TNF-α is also overexpressed in the fat and muscle of obese humans [9, 10] . In mammalian cells, TNF-α binds to two distinct receptors, p55 and p75 TNF receptors, that transmit signals to the cytoplasm and the nucleus [15] . In adipocytes, stimulation of the p55 TNF receptors is sufficient to inhibit insulin signalling [16] . Two second messengers, sphingosine and ceramide, are formed after the binding of TNF-α to its receptor [17] . In 3T3-L1 adipocytes, the exogenous addition Abbreviations used : ERK, extracellular signal-regulated protein kinase ; IGF-I, insulin-like growth factor I ; IL, interleukin ; JNK, c-Jun N-terminal kinase ; MAPK, mitogen-activated protein kinase ; NF-κB, nuclear factor κB ; SMIT, Na + /myo-inositol co-transporter ; TGF-β, transforming growth factor β ; TLCK, 7-amino-1-chloro-3-L-tosylamidoheptan-2-one ; TNF-α, tumour necrosis factor α. 1 To whom correspondence should be addressed (e-mail myorek!icva.gov).
activated protein kinase kinase pathway activity ; however, with the possible exception of c-Jun N-terminal kinase, this pathway does not seem to regulate SMIT mRNA levels or myo-inositol accumulation. TNF-α activates nuclear factor κB (NF-κB) in 3T3-L1 adipocytes but, unlike the effect of TNF-α on cultured endothelial cells, NF-κB does not seem to contribute to the regulation by TNF-α of SMIT gene expression in 3T3-L1 adipocytes. Therefore other signal transduction pathways must be considered in the regulation by TNF-α of SMIT mRNA levels and activity. Thus TNF-α and hyperosmolarity have opposing effects on SMIT mRNA levels and activity in 3T3-L1 adipocytes.
Because myo-inositol in the form of phosphoinositides is an important component of membranes and signal transduction pathways, the regulation of myo-inositol metabolism by TNF-α might represent another mechanism by which TNF-α regulates adipocyte function.
of cell-permeable ceramides duplicates the effect of TNF-α on insulin-stimulated glucose uptake [7, 18] . Insulin resistance, a subnormal biological response to insulin, is a systemic phenomenon associated with several diseases, including chronic infection, cancer, obesity and non-insulindependent diabetes mellitus [19] . Several laboratories have shown that TNF-α is an important mediator of insulin resistance ; however, the mechanism(s) by which TNF-α interferes with insulin action are not well understood [19] . Some of the effects of TNF-α on adipocytes include transcriptional repression of the gene for GLUT4, decreased GLUT4 mRNA stability, decreased insulin-stimulated autophosphorylation of the insulin receptor and phosphorylation of insulin receptor substrate 1, inhibition of lipoprotein lipase gene transcription and decreased DNA-binding activity and expression of the transcription factor CCAAT\ enhancer binding protein [8, [20] [21] [22] [23] . Here we show that another effect of TNF-α on adipocytes is a decrease in SMIT mRNA levels and myo-inositol accumulation. Because myo-inositol uptake is important for maintaining phosphoinositide production in mammalian cells, and signalling pathways that utilize the phosphoinositide pool mediate insulin action, it is possible that a decrease in myo-inositol metabolism in adipocytes could have an impact on insulin signalling [1, 24] .
In the present study we also examined the effect of hyperosmolarity on SMIT mRNA levels and myo-inositol accumulation. Because stress factors such as hyperosmolarity have been shown to induce the same signal transduction pathways as those of cytokines, the effect of hyperosmolarity was examined to compare and contrast its effect with TNF-α and to help elucidate the mechanism responsible for the TNF-α effect [25, 26] . In endothelial cells and other cultured mammalian cells, hyperosmolarity has been shown to increase SMIT mRNA levels and myo-inositol transport [27] [28] [29] [30] [31] . However, the effect of hyperosmolarity on adipocytes has not been examined.
EXPERIMENTAL Materials
Recombinant human TNF-α was obtained from Research & Development Systems (Minneapolis, MN, U.S.A.). The specific activity was 0.02 ng\ml, on the basis of a cytotoxicity assay with L-929 cells. The endotoxin level was less than 0.1 ng\µg of cytokine as determined by the Limulus amoebocyte lysate assay. 
Cell culture
The murine 3T3-L1 fibroblasts used in this study were obtained from the American Type Culture Collection (Rockville, MD, U.S.A.). Cells were cultured, maintained and differentiated as described previously [32] .
myo-Inositol accumulation
For the determination of myo-inositol accumulation, 3T3-L1 adipocytes were incubated in Dulbecco's modified Eagle's medium (serum-free) containing 0.5 % BSA for 1-24 h in the absence or presence of 0.1-10 ng\ml TNF-α or 50-300 mM raffinose to induce hyperosmolarity as described previously [1, 30] . For many of these studies myo-inositol accumulation was determined after a 30 min incubation. In these studies, ' myo-inositol accumulation ' represents the cellular accumulation of radioactivity derived from myo- [2-$H] [33] , indicating that neither TNF-α nor hyperosmolarity was cytotoxic.
For reversion studies, adipocytes were preincubated, as described above, for 24 h in serum-free medium with 0.5 % BSA containing 10 ng\ml TNF-α or 150 mM raffinose. The adipocytes were then washed with isotonic serum-free medium and incubated in this medium for 1-24 h. After selected periods of time, SMIT mRNA levels (see below) or myo-inositol accumulation was determined as described above.
We also determined the effect of C ' -ceramide, sphingosine, insulin, cytokines, growth factors, PMA or hyperglycaemia on myo-inositol accumulation or SMIT mRNA levels by 3T3-L1 adipocytes. For these studies, 3T3-L1 adipocytes were incubated as described in the figure and table legends. Afterwards myoinositol accumulation was determined as described above. We also examined the effect of actinomycin D or cycloheximide on hyperosmolarity-induced changes in myo-inositol accumulation and on changes in SMIT mRNA levels induced by TNF-α or hyperosmolarity. For these studies, 3T3-L1 adipocytes were preincubated with 5 µM actinomycin D or 25 µM cycloheximide for 1 h before the addition of either 10 ng\ml TNF-α or 150 mM raffinose ; the incubations were performed as indicated. Afterwards myo-inositol accumulation or SMIT mRNA was determined. In studies examining the effect of inhibitors on the changes in myo-inositol accumulation induced by TNF-α or hyperosmolarity, 3T3-L1 adipocytes were preincubated for 1 h in serum-free medium with 0.5 % BSA in the absence or presence of each inhibitor at the concentrations indicated in Table 2 . Afterwards 10 ng\ml TNF-α or 150 mM raffinose was added ; the incubation continued for an additional 16 h. The accumulation of myo-inositol was then determined as described above.
Kinetic parameters for high-affinity and low-affinity myoinositol transport were determined by incubating 3T3-L1 adipocytes for 5 min in Hepes buffer with or without NaCl and containing 5-1000 µM myo-[2-$H]inositol as described previously [1] .
To determine the effect of TNF-α or hyperosmolarity on the intracellular myo-inositol and sorbitol content, 3T3-L1 adipocytes were grown in 25 cm# flasks, then incubated in serumfree medium with 0.5 % BSA in the absence or presence of 10 ng\ml TNF-α or 150 mM raffinose for 24 h. Afterwards the adipocytes were washed with glucose-free Hepes buffer, collected in water and sonicated. Aliquots of the cell suspension were taken for protein determination ; derivatized samples were analysed as described previously [1] .
RNA isolation and quantification of SMIT mRNA levels
RNA was prepared by using the guanidine isothiocyanate\CsCl method. RNA was quantified by measuring the absorbance at 260 nm, and the integrity of the RNA and accuracy of quantification were confirmed by size-separating the RNA by denaturing gel electrophoresis and comparing the intensity of the 18 S and 28 S ribosomal RNA bands after staining of the gel with ethidium bromide [1] . SMIT mRNA levels in 3T3-L1 adipocytes were quantified with a solution hybridization\RNase protection assay as described previously [1, 30] .
Mitogen-activated protein kinase (MAPK) assays
MAPK assays were performed with an immune complex kinase assay as described previously [34] . In brief, adipocytes were treated as indicated and lysed in 50 mM Tris\HCl, pH 7.5, containing 150 mM NaCl, 1 % (v\v) Nonidet P40, 0.5 % deoxycholate, 0.1 % SDS, 1 mM sodium orthovanadate, 0.12 mM PMSF and 0.7 µg\ml leupeptin. After a low-speed centrifugation (to remove the lipid plug) and clarification, 250 µg of cell lysate protein was incubated with anti-(extracellular signal-regulated protein kinase 1) (anti-ERK1), anti-ERK2, anti-(c-Jun N-terminal kinase 1) (anti-JNK1), anti-JNK2 or anti-(p38 kinase) antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) that had been prebound to Protein A-agarose beads (Pierce Chemical Co., Rockford, IL, U.S.A.). The beads were collected and washed, then resuspended in kinase buffer [25 mM Hepes (pH 7.4)\10 mM MgCl
To the reaction mix were added the substrates myelin basic protein (Upstate Biotechnology, Lake Placid, NY, U.S.A.) for ERK1 and ERK 2 determination, c-Jun (1-81) (Santa Cruz Biotechnology) for JNK1 or JNK2 determination, or activating transcription factor (ATF)-2 (1-96) (Santa Cruz Biotechnology) for p38 kinase determination, at a final concentration of 167 µg\ml, together with 500 µCi\ml [γ-$#P]ATP. The reaction continued for 20 min at 22 mC and was terminated by the addition of Laemmli sample buffer. The phosphorylated reaction products were then separated by SDS\PAGE. The resulting gel was dried and exposed to X-ray film to determine the $#P incorporation into each substrate by using a scanning densitometer. Each assay was conducted in duplicate with two separately prepared cell lysates.
Electrophoretic mobility-shift assay
3T3-L1 adipocytes were incubated for 30 min in serum-free medium containing 10 ng\ml TNF-α, 100 µM C ' -ceramide, 100 µM sphingosine or 150 mM raffinose. Afterwards the adipocytes were washed and harvested with PBS at 4 mC followed by a low-speed centrifugation. The adipocytes were resuspended in 1.5 ml of buffer A [10.0 mM Hepes (pH 8.0)\1.5 mM MgCl # \ 10.0 mM KCl\0.5 mM dithiothreitol\300 mM sucrose\0.1 % (v\v) Nonidet P40\1 µg\ml pepstatin\1 µg\ml antipain\1 µg\ml chymostatin\1 µg\ml aprotinin\0.1 µg\ml leupeptin\0.5 mM PMSF] and incubated on ice for 5 min. The crude nuclear pellet was then collected by microcentrifugation for 2 min at 4 mC. Afterwards the pellet was quickly washed with buffer A and resuspended in buffer B [20 mM Hepes (pH 8.0)\20 % (v\v) glycerol\100 mM KCl\100 mM NaCl\0.2 mM EDTA\0.5 mM PMSF\0.5 mM dithiothreitol\1 µg\ml pepstatin\1 µg\ml antipain\1 µg\ml chymostatin\1 µg\ml aprotinin\0.1 µg\ml leupeptin]. The isolated nuclei were sonicated for 10 s at 4 mC and clarified by microcentrifugation. The protein concentration of the extract was determined ; the extract was then stored at k70 mC until assayed. For gel mobility-shift assays, annealed oligonucleotides containing the consensus sequence for nuclear factor κB (NF-κB) (5h-TTTCGCGGGGACTTTCCCGCGC-3h ; 5h-TTTGCGCGGGAAAGTCCCCGCG-3h) and the E-box of the adenovirus major late transcription factor promoter (5h-ATAGGTGTAGGCCACGTGACCGGGTGT-3h ; 5h-ACACC-CGGTCACGTG-3h) were radiolabelled with [α-$#P]dATP and unlabelled dGTP, dCTP and dTTP by using Klenow DNA polymerase, then gel-purified as described previously [1] . Nuclear extract (15 µg) was preincubated for 10 min at 25 mC with 1 µg of poly(dI-dC):poly(dI-dC) under ionic conditions. Radiolabelled probe (5i10% c.p.m. ; approx. 2 ng) was added to each 20 µl reaction and incubated for 15 min at 37 mC. Samples were analysed on a non-denaturing 5 % (w\v) polyacrylamide gel in 0.5iTris\borate\EDTA [45 mM Tris\borate\1 mM EDTA (pH 8.0)] and subjected to electrophoresis at 115 V for 3 h at 25 mC. Gels were then dried and autoradiographs were exposed for the appropriate period at k70 mC with intensifying screens.
Data analysis
All results are expressed as meanspS.E.M. Results for myoinositol accumulation and myo-inositol and sorbitol content are reported as nmol\mg of cell protein. Results for SMIT mRNA levels are reported as percentages of control. Statistical comparisons for significance were performed with ANOVA and an unpaired Student's t-test or Dunnett's analysis at a P value of 0.05.
RESULTS

Effect of TNF-α and hyperosmolarity on SMIT mRNA levels and myo-inositol accumulation
To determine the effect of TNF-α and hyperosmolarity on SMIT mRNA levels and myo-inositol accumulation, 3T3-L1 adipocytes were incubated for 16 h in serum-free medium containing 0.5 %
Figure 1 Effect of TNF-α or hyperosmolarity on myo-inositol accumulation and SMIT mRNA levels in 3T3-L1 adipocytes
3T3-L1 adipocytes were incubated in serum-free medium with 0.5 % BSA containing no additions (control) or 10 ng/ml TNF-α or 150 mM raffinose (hyperosmolarity) for 16 h. Afterwards myo-inositol accumulation was determined by washing the cells with osmotically matched M199 serum-free medium containing 0.5 % BSA and then incubating the cells in this medium containing myo- [2- 3 H]inositol as described in the Experimental section. For these studies, cells were incubated for 5-60 min. For SMIT mRNA determination, cells were incubated as described above and then RNA was isolated and SMIT and β-actin mRNA levels were determined as described in the Experimental section. Results are presented as nmol/mg of protein for myo-inositol accumulation. Each value is the meanpS.E.M. for nine separate determinations. The inset shows a representative autoradiogram of SMIT and β-actin mRNA levels. + P 0.05, significant decrease compared with control ; * P 0.05, significant increase compared with control.
Figure 2 Concentration and time-course effect of TNF-α on myo-inositol accumulation and SMIT mRNA levels in 3T3-L1 adipocytes
3T3-L1 adipocytes were incubated in serum-free medium with 0.5 % BSA containing 0-10 ng/ml TNF-α (concentration response ; left panel) for 16 h, or 10 ng/ml TNF-α for 0-24 h (time course ; right panel). Afterwards myo-inositol accumulation was determined by washing the cells with M199 serum-free medium containing 0.5 % BSA and then incubating the cells in this medium containing myo- [2- 3 H]inositol for 30 min as described in the Experimental section. For SMIT mRNA determination, cells were incubated as described above and then RNA was isolated and SMIT mRNA levels were determined as described in the Experimental section. SMIT mRNA levels were standardized to 18 S rRNA levels. Results are presented as nmol/mg of protein for myo-inositol accumulation or as percentages of control for the SMIT mRNA levels, with the level of SMIT mRNA in control cells assigned a value of 1. Each value is the meanpS.E.M. for nine separate determinations for myo-inositol accumulation, or four separate determinations for SMIT mRNA levels. *P 0.05 compared with control.
BSA in the absence or presence of 10 ng\ml TNF-α or 150 mM raffinose. Afterwards SMIT mRNA levels (Figure 1, inset) and myo-inositol uptake over a 5-60 min incubation were determined ( Figure 1) . myo-Inositol accumulation by 3T3-L1 adipocytes was linear over the 60 min incubation period. Treatment of adipocytes with TNF-α significantly decreased myo-inositol accumulation at all time points, whereas hyperosmolarity significantly increased myo-inositol accumulation. SMIT mRNA levels were decreased to 25 % of control levels by TNF-α. In contrast, hyperosmolarity stimulated an approx. 5-fold increase in SMIT mRNA levels. The results in Figure 2 show a concentration response and time course for the effect of TNF-α on myo-inositol accumulation and SMIT mRNA levels. TNF-α (1 ng\ml) caused a significant decrease in both SMIT mRNA levels and myo-inositol accumulation. Treatment of 3T3-L1 adipocytes with 10 ng\ml TNF-α for 3 h caused a significant decrease in both SMIT mRNA levels and myo-inositol accumulation, with maximal effects on myo-inositol accumulation after a 12 h incubation. The effect of hyperosmolarity on SMIT mRNA levels and myoinositol accumulation was also concentration-and time-dependent ( Figure 3) . Exposure of 3T3-L1 adipocytes for 16 h to medium containing 50 mM raffinose, which increased the osmolarity of the medium from approx. 310 to 358 m-osM, significantly increased both SMIT mRNA levels and myo-inositol accumulation. Maximum effects were observed with 150 mM raffinose. The time-course study revealed that the hyperosmolarity-induced increase in SMIT mRNA levels preceded the increase in myoinositol accumulation and that a 6 h exposure to medium containing 150 mM raffinose maximally stimulated SMIT mRNA levels.
To determine the effect of TNF-α and hyperosmolarity on the cellular content of myo-inositol or sorbitol in 3T3-L1 adipocytes, the cells were incubated for 24 h in serum-free medium containing 3 H]inositol for 30 min as described in the Experimental section. For SMIT mRNA determination, cells were incubated as described above and then RNA was isolated and SMIT mRNA levels were determined as described in the Experimental section. SMIT mRNA levels were standardized to β-actin mRNA or 18 S rRNA levels. Results are presented as nmol/mg of protein for myoinositol accumulation or as percentages of control for the SMIT mRNA levels, with the level of SMIT mRNA in control cells assigned a value of 1. Each value is the meanpS.E.M. for six separate determinations for myo-inositol accumulation, or three separate determinations for SMIT mRNA levels. *P 0.05 compared with control. 0.5 % BSA in the absence or presence of 10 ng\ml TNF-α or 150 mM raffinose. The myo-inositol content of 3T3-L1 adipocytes was decreased significantly from 183.6p3.6 to 150.8p6.2 nmol\ mg of protein (P 0.05) by TNF-α. In contrast, the myo-inositol content was increased significantly (260.9p14.8 nmol\mg of protein ; P 0.05) after exposure of 3T3-L1 adipocytes for 24 h to hyperosmotic conditions. If we assume that the intracellular volume of these cells is approx. 10 µl for 1 mg of cell protein, the intracellular concentration of myo-inositol in these cells would be approx. 18 mM and increased by approx. 40 % after exposure of the cells to hyperosmotic conditions. Aldose reductase activity was apparently increased by hyperosmolarity in 3T3-L1 adipocytes because sorbitol levels were increased in 3T3-L1 adipocytes exposed to hyperosmotic medium (8.7p 2.2 nmol\mg of protein). Sorbitol was not detected in 3T3-L1 adipocytes incubated in isotonic medium.
A study of myo-inositol transport by 3T3-L1 adipocytes demonstrated that, like many other mammalian cells, 3T3-L1 adipocytes take up myo-inositol by high-affinity and low-affinity transport systems [35] . The high-affinity myo-inositol transport system in 3T3-L1 adipocytes has a K m of 48.8p11.9 µM and a V max of 171.1p21.5 pmol\min per mg of protein, whereas the low-affinity system has a K m of 2.47p0.72 mM and a V max of 969.2p155.6 pmol\min per mg of protein. To determine whether TNF-α or hyperosmolarity affects the high-affinity myo-inositol transport system, 3T3-L1 adipocytes were incubated in serumfree medium containing 0.5 % BSA for 16 h in the absence or presence of 10 ng\ml TNF-α or 150 mM raffinose. Neither TNF-α nor hyperosmolarity had a significant effect on the K m for high-affinity myo-inositol transport in 3T3-L1 adipocytes (51.7p5.7, 65.6p6.6 and 53.6p9.9 µM for control, TNF-α-treated and hyperosmolarity-treated cells respectively). In con- Figure 4 Effect of TNF-α, C 6 -ceramide, sphingosine, insulin or hyperosmolarity on myo-inositol accumulation and SMIT mRNA levels in 3T3-L1 adipocytes 3T3-L1 adipocytes were incubated in serum-free medium with 0.5 % BSA containing no additions (control ; condition 1), 10 ng/ml TNF-α (condition 2), 100 µM C 6 -ceramide (condition 3), 100 µM sphingosine (condition 4), 100 nM insulin (condition 5) or 150 mM raffinose (hyperosmolarity ; condition 6) for 16 h. Afterwards myo-inositol accumulation was determined by washing the cells with osmotically matched M199 serum-free medium containing 0.5 % BSA and then incubating the cells in osmotically matched medium containing myo- [2- 3 H]inositol for 30 min as described in the Experimental section. For SMIT mRNA determination, cells were incubated as described above, and then RNA was isolated and SMIT mRNA levels were determined as described in the Experimental section. SMIT mRNA levels were standardized to β-actin mRNA levels. Data are presented as nmol/mg of protein for myo-inositol accumulation or as percentages of control for the SMIT mRNA levels, with the level of SMIT mRNA in control cells assigned a value of 1. The inset shows a representative autoradiogram for SMIT and β-actin mRNA levels. Each value is the meanpS.E.M. for five separate determinations. * P 0.05, significant decrease compared with control. + P 0.05, significant increase compared with control.
trast, exposure of 3T3-L1 adipocytes to TNF-α caused a significant decrease in the V max for high-affinity myo-inositol transport (188.5p10.8 and 133.3p7.8 pmol\min per mg of protein for control and TNF-α-treated cells respectively ; P 0.05), whereas exposure of cells to hyperosmotic conditions caused a significant increase in the V max for high-affinity myo-inositol transport (564.4p49.4 pmol\min per mg of protein ; P 0.05 compared with control).
The effect of C 6 -ceramide, sphingosine and insulin on SMIT mRNA levels and myo-inositol accumulation
Because ceramide and sphingosine are considered to be second messengers generated by mammalian cells after the binding of TNF-α to its receptor, we examined the effect of exogenous C ' -ceramide and sphingosine on SMIT mRNA levels and myoinositol accumulation by 3T3-L1 adipocytes [36] . Neither C ' -ceramide nor sphingosine significantly altered SMIT mRNA levels or myo-inositol accumulation (Figure 4 ). Because insulin stimulates glucose transport in 3T3-L1 adipocytes, we also determined whether insulin alters myo-inositol uptake in these cells [7, 8, 18, 23] . Results in Figure 4 show that insulin did not significantly change SMIT mRNA levels or myo-inositol accumulation in 3T3-L1 adipocytes [ Figure 4 (inset) shows a representative autoradiogram of SMIT mRNA and β-actin mRNA levels]. In contrast, glucose uptake was significantly increased by more than 10-fold by insulin in these cells (results not shown). 
Effect of growth factors, cytokines, PMA and hyperglycaemia on myo-inositol accumulation by 3T3-L1 adipocytes
To determine the specificity of the effect of TNF-α and hyperosmolarity on myo-inositol accumulation we examined the effect of other growth factors, cytokines, PMA and hyperglycaemia on myo-inositol accumulation in 3T3-L1 adipocytes. As shown in Table 1 , treatment of 3T3-L1 adipocytes for 16 h with insulin, IGF-I, platelet-derived growth factor or TGF-β did not affect myo-inositol accumulation. Similarly, exposure of 3T3-L1 adipocytes for 16 h to 50 mM glucose, the phorbol ester PMA or the cytokines IL-1α, IL-1β, IL-2 or IL-6 did not alter myoinositol accumulation.
Effect of actinomycin D or cycloheximide on TNF-α-and hyperosmolarity-induced changes in SMIT mRNA levels and/or myo-inositol accumulation
To determine whether RNA or protein synthesis is required for the effect of TNF-α or hyperosmolarity on SMIT mRNA levels and\or myo-inositol accumulation by 3T3-L1 adipocytes, we preincubated the cells with either 5 µM actinomycin D or 25 µM cycloheximide before treatment with TNF-α or 150 mM raffinose. Actinomycin D blocked the TNF-α-induced decrease in SMIT mRNA levels (results not shown). Actinomycin D or cycloheximide pretreatment blocked the hyperosmolarityinduced increase in myo-inositol accumulation by 3T3-L1 adipocytes (results not shown). Furthermore actinomycin D pretreatment blocked the effect of hyperosmolarity on SMIT mRNA levels (results not shown).
Reversion of the effect of TNF-α and hyperosmolarity on SMIT mRNA levels and myo-inositol accumulation
To determine the reversibility of TNF-α-and hyperosmolarityinduced changes in SMIT expression and myo-inositol accumulation, 3T3-L1 adipocytes treated with TNF-α or hyperosmotic medium for 24 h were returned to normal isotonic medium. The TNF-α-induced decrease in SMIT mRNA levels and myo-inositol accumulation in 3T3-L1 adipocytes was reversible after removing
Figure 5 Reversion of the effect of TNF-α on myo-inositol accumulation and SMIT mRNA levels in 3T3-L1 adipocytes
3T3-L1 adipocytes were incubated in serum-free medium with 0.5 % BSA in the absence or presence of 10 ng/ml TNF-α for 24 h. Afterwards some of the cells that had been exposed to medium containing TNF-α were washed three times with serum-free medium and then incubated in serum-free medium in the absence of TNF-α for up to 24 h. After this incubation, myo-inositol accumulation was determined by washing the cells with M199 serum-free medium containing 0.5 % BSA and then incubating the cells in this medium containing myo- [2- 3 H]inositol for 30 min as described in the Experimental section. For SMIT mRNA determination, cells were incubated as described above, and then RNA was isolated and SMIT mRNA levels were determined as described in the Experimental section. SMIT mRNA levels were standardized to β-actin mRNA levels. Results are presented as nmol/mg of protein for myoinositol accumulation or as percentages of control for the SMIT mRNA levels, with the level of SMIT mRNA in control cells assigned a value of 1. Each value is the meanpS.E.M. for six separate determinations for myo-inositol accumulation and SMIT mRNA levels. the cells from the medium containing TNF-α ( Figure 5 ). Recovery of SMIT mRNA levels preceded the recovery of myo-inositol accumulation and was complete within 6 h. Recovery of myoinositol accumulation was complete after about 24 h. The hyperosmolarity-induced increase in SMIT mRNA levels and myo-inositol accumulation was also reversible (Figure 6 ). Incubation of hyperosmolarity-induced 3T3-L1 adipocytes for 3 h in isotonic medium resulted in a significant decrease in SMIT mRNA levels and myo-inositol accumulation compared with cells maintained in hyperosmotic medium. Complete normalization of SMIT mRNA levels and myo-inositol accumulation occurred within 24 h.
Effect of TNF-α-and hyperosmolarity on MAPK activity in 3T3-L1 adipocytes
To determine whether TNF-α and hyperosmolarity might be having different effects on signalling pathways in 3T3-L1 adipocytes, thereby explaining the opposing effects of TNF-α and hyperosmolarity on SMIT mRNA levels and myo-inositol accumulation, we examined MAPK kinase activity in control 3T3-L1 adipocytes ( Figure 7 , lanes A) and after a 10 min incubation with 150 mM raffinose ( Figure 7, lanes B) , 100 nM insulin ( Figure 7 , lanes C) or 10 ng\ml TNF-α ( Figure 7 , lanes D). Treatment of 3T3-L1 adipocytes with insulin was included in these studies for comparative purposes. Insulin increased ERK1 (8.2-fold), ERK2 (3.7-fold) and p38 kinase (1.5-fold) activity in 3T3-L1 adipocytes. Hyperosmolarity increased ERK1 (1.3-fold), JNK1 (3.6-fold), JNK2 (2.1-fold) and p38 kinase (2.2-fold) Figure 6 Reversion of the effect of hyperosmolarity on myo-inositol accumulation and SMIT mRNA levels in 3T3-L1 adipocytes 3T3-L1 adipocytes were incubated in serum-free medium with 0.5 % BSA in the absence or presence of 150 mM raffinose (Hyper) for 24 h. Afterwards some of the cells that had been exposed to hyperosmotic medium were washed three times with serum-free medium and then incubated in isotonic serum-free medium for up to 24 h. After this incubation, myo-inositol accumulation was determined by washing the cells with osmotically matched M199 serum-free medium containing 0.5 % BSA and then incubating the cells in osmotically matched M199 serum-free medium containing myo- [2- 3 H]inositol for 30 min as described in the Experimental section. For SMIT mRNA determination, cells were incubated as described above and then RNA was isolated and SMIT mRNA levels were determined as described in the Experimental section. SMIT mRNA levels were standardized to β-actin mRNA levels. Results are presented as nmol/mg of protein for myo-inositol accumulation or as percentages of control for the SMIT mRNA levels, with the level of SMIT mRNA in control cells assigned a value of 1. Each value is the meanpS.E.M. for six separate determinations for myo-inositol accumulation, or four separate determinations for SMIT mRNA levels. * P 0.05 compared with control ; + P 0.05 compared with hyperosmolarity-treated cells.
activity, whereas TNF-α marginally increased only JNK1 (1.4-fold) and JNK2 (1.4-fold) activity in 3T3-L1 adipocytes.
Effect of TNF-α and hyperosmolarity on NF-κB activation in 3T3-L1 adipocytes
We have previously shown that the activation of NF-κB by TNF-α in cultured endothelial cells is associated with the TNF-α-induced decrease in myo-inositol accumulation [1] . We therefore examined the effect of TNF-α on NF-κB activation in 3T3-L1 adipocytes. By electrophoretic mobility-shift assay we determined that TNF-α causes a concentration-and time-dependent activation of NF-κB in 3T3-L1 adipocytes with maximal activity obtained after a 15 min incubation (results not shown). In contrast with the effect of TNF-α, neither C ' -ceramide, sphingosine nor hyperosmolarity activated NF-κB in 3T3-L1 adipocytes (results not shown).
Effect of kinase inhibitors, ceramidase inhibitor, protease inhibitor and inhibitors of NF-κB on TNFα-or hyperosmolarity-induced changes in myo-inositol accumulation in 3T3-L1 adipocytes
TNF-α activates a variety of signal transduction pathways, including protein kinase C, phospholipase A # and protein phosphorylation of serine\threonine and tyrosine residues, whereas TNF-α and hyperosmolarity have both been shown to activate the MAPK pathway in mammalian cells [36] [37] [38] [39] [40] . In an attempt to determine the signal transduction pathway(s) responsible for the effects of TNF-α and hyperosmolarity on myoinositol accumulation, we examined the effect of various
Figure 7 Effect of hyperosmolarity, insulin or TNF-α on mitogen-activated protein kinase kinase activity in 3T3-L1 adipocytes
3T3-L1 adipocytes were incubated in serum-free medium with 0.5 % BSA containing no additions (control, lanes A), 150 mM raffinose (hyperosmolarity, lanes B), 100 nM insulin (lanes C) or 10 ng/ml TNF-α (lanes D) for 10 min. Afterwards the cells were washed, lysates were prepared and assays for ERK1, ERK2, JNK1, JNK2 and p38 kinase were performed as described in the Experimental section.
Table 2 Effect of kinase inhibitors, ceramidase inhibitor and inhibitors of NF-κB activation on TNF-α-or hyperosmolarity-induced changes in myoinositol accumulation by 3T3-L1 adipocytes
3T3-L1 adipocytes were preincubated in serum-free medium containing 0.5 % BSA and the different inhibitors indicated for 1 h. Afterwards the medium was changed and some of the cells were treated with 10 ng/ml TNF-α or 150 mM raffinose (hyperosmolarity) in the absence or presence of the different inhibitors. This incubation was continued for an additional 16 h and then myo-inositol accumulation (shown as the percentage of control) was determined as described in the Experimental section. Results are meanspS.E.M. for nine (TNF-α studies) or six (hyperosmolarity studies) separate determinations. * P 0.05 compared with untreated cells. Abbreviation : n.d., not determined.
myo-Inositol accumulation (% of control)
TNF-α Hyperosmolarity
90p12 59p11* 127p19 365p57* Wortmannin (100 nM) 96p13 54p9* 133p22 392p31* Rapamycin (10 µM) 93p9 51p2* 118p14 335p51* PD-98059 (10 µM) 105p10 66p6* 144p13 455p63* SB-203580 (100 µM) 90p6 58p7* 86p13 278p36* inhibitors of phosphorylation, protease degradation, NF-κB activation and ceramidase activity on TNF-α-and\or hyperosmolarity-induced changes in myo-inositol accumulation ( Table  2) . Inhibitors of NF-κB activation, pyrrolidine dithiocarbamate, TLCK (a protease inhibitor used to inhibit I-κB-α degradation) and genistein [a protein tyrosine kinase inhibitor used to block the phosphorylation of the inhibitor of NF-κB (I-κB-α)], did not prevent the TNF-α-induced decrease in myo-inositol accumulation. In separate studies, we showed that each of these compounds prevented, to a different degree (50-100 %), the TNF-α-induced activation of NF-κB in 3T3-L1 adipocytes (results not shown). Genistein did not prevent the hyperosmolarity-induced increase in myo-inositol accumulation.
Inhibitors of ERK1 (PD-98059), p38 kinase (SB-203580), p70 S6 kinase (rapamycin) or phosphatidylinositol 3-kinase (wortmannin) did not affect either the TNF-α-or hyperosmolarity-induced changes in myo-inositol accumulation.
Inhibitors of protein kinase C, including calphostin C, staurosporin and H7, were also found to have no effect on the TNF-α-or hyperosmolarity-induced changes in myo-inositol accumulation (results not shown). Lastly, N-oleoylethanolamine, a ceramidase inhibitor, had no effect on the TNF-α-induced decrease in myo-inositol accumulation.
DISCUSSION
myo-Inositol is acquired by mammalian cells through an active, Na + -dependent co-transporter, and the internal concentration of myo-inositol is generally 5-500-fold higher than the level of myoinositol in plasma or extracellular fluid. myo-Inositol is a component of cellular membranes and, in the form of phosphoinositides, is an integral part of several signal transduction pathways, including phosphatidylinositol 3-kinase and the phosphatidylinositol cycle. In addition, myo-inositol is an organic osmolyte, and the regulation of its transport is important for maintaining an osmotic balance during periods of osmotic stress [27] [28] [29] [30] [31] . In the present study we have shown that 3T3-L1 adipocytes, like other mammalian cells, acquire myo-inositol by way of the SMIT, and that SMIT activity is mediated by hyperosmolarity and TNF-α [15, 16, 18, 19] . Because TNF-α and hyperosmolarity are well-known cellular stress factors and activate similar signal transduction pathways, we postulated that they would have similar effects on SMIT mRNA levels and activity [13, 14] . However, in cultured endothelial cells and 3T3-L1 adipocytes, TNF-α and hyperosmolarity have opposite effects on SMIT mRNA levels and myo-inositol accumulation [1] . Hyperosmolarity has been shown to increase the uptake of myo-inositol by a variety of mammalian cells, including renal, neural and endothelial cells [27] [28] [29] [30] [31] . Studies by Yamauchi et al. [28] have shown that this is due to an increase in transcription of the SMIT gene. Previously, investigation of the regulation in the metabolism of two other organic osmolytes, sorbitol and betaine, led to the identification of osmotic response elements on the aldose reductase gene and betaine transporter gene, suggesting that increased transcription of these genes in response to hyperosmolarity was responsible for increasing sorbitol production and betaine uptake respectively [41, 42] . Recently the SMIT gene has also been characterized and an osmotic response element identified [43] . Because actinomycin D blocked the induction by hyperosmolarity of SMIT mRNA levels and activity, and cycloheximide blocked the hyperosmolarity-induced increase in myoinositol accumulation without affecting the increase in SMIT mRNA levels, it is likely that the effect of hyperosmolarity on myo-inositol uptake by 3T3-L1 adipocytes is due to the regulation of SMIT gene transcription. 3T3-L1 adipocytes were very sensitive to changes in osmolarity, as demonstrated by the increase in SMIT mRNA levels and myo-inositol accumulation in response to a small change in osmolarity (50 mM raffinose), and the rapid increase in SMIT mRNA levels 3 h after exposure to 150 mM raffinose that preceded an increase in myo-inositol accumulation. Because the hyperosmolarity-induced increase in myo-inositol levels in 3T3-L1 adipocytes greatly exceeded the increase in sorbitol levels, it seems likely that myo-inositol is the major osmolyte in adipocytes for regulating changes in osmotic stress.
TNF-α has been shown to decrease GLUT4 mRNA levels in 3T3-L1 adipocytes ; in adipocytes this is thought to contribute to insulin resistance [7, 8, 16, 18, 23] . The TNF-α-induced decrease in GLUT4 mRNA levels and insulin-stimulated glucose transport in 3T3-L1 adipocytes were caused by a decrease in GLUT4 gene transcription and mRNA stability [7, 8, 18, 23] . We observed a similar effect of TNF-α on SMIT mRNA levels and myo-inositol accumulation. Studies with actinomycin D to block mRNA synthesis suggest that the effect of TNF-α on SMIT mRNA levels requires mRNA synthesis, although an additional effect of TNF-α on SMIT mRNA stability cannot be excluded. In bovine aortic endothelial cells, TNF-α is known to modulate the expression of a protein that regulates the stability of endothelial nitric oxide synthase mRNA levels [44] . Studies are currently being conducted to determine whether TNF-α might be regulating SMIT mRNA stability by a similar mechanism.
We have shown previously that TNF-α decreases SMIT mRNA levels and myo-inositol accumulation in cultured endothelial cells [1] . As in endothelial cells, the effect of TNF-α on 3T3-L1 adipocyte SMIT mRNA levels and myo-inositol accumulation was reversible and caused a decrease in the V max without affecting the K m for high-affinity myo-inositol transport. The latter observation suggests that the effect of TNF-α on myoinositol metabolism in 3T3-L1 adipocytes and endothelial cells might be due to a decrease in the amount of myo-inositol transporter present on the plasma membrane. Our SMIT mRNA results are consistent with this, but confirmation of this finding will require Western blot analysis of the SMIT protein with an antibody that is presently not available.
Our studies showed that several different growth factors (IL-1α, IL-1β, IL-2, IL-6), PMA and hyperglycaemia did not affect myo-inositol accumulation by 3T3-L1 adipocytes. In cultured aorta and pulmonary artery endothelial cells, IL-1β and TGF-β were found to mimic the effects of TNF-α on myo-inositol accumulation [1] . However, in 3T3-L1 adipocytes, decreased myo-inositol accumulation was observed only after treatment with TNF-α, indicating a highly specific and sensitive mechanism of regulation of myo-inositol metabolism in 3T3-L1 adipocytes by TNF-α. In studies of cultured renal cells, PMA has been shown to decrease myo-inositol uptake [45] . However, such a mechanism does not seem to be present in 3T3-L1 adipocytes.
Two second messengers, sphingosine and ceramide, are formed after the binding of TNF-α to its receptor [17] . In 3T3-L1 adipocytes, the exogenous addition of cell-permeable ceramides duplicates the effects of TNF-α on insulin-stimulated glucose uptake [7, 18] . In cultured endothelial cells, TNF-α and the exogenous addition of C ' -ceramide were shown to decrease SMIT mRNA levels and myo-inositol accumulation [1] . However, in 3T3-L1 adipocytes, treatment with exogenous C ' -ceramide or sphingosine did not duplicate the effects of TNF-α on SMIT mRNA levels or myo-inositol accumulation. Therefore there seems to be a primary difference in the mechanism by which TNF-α exerts its effects on (1) SMIT mRNA levels and myoinositol accumulation in endothelial cells and 3T3-L1 adipocytes, and (2) GLUT4 mRNA levels, insulin-stimulated glucose transport, SMIT mRNA levels and myo-inositol accumulation in 3T3-L1 adipocytes. The reasons for these differences are currently not clear. In cultured endothelial cells, the effect of TNF-α on SMIT mRNA levels and myo-inositol accumulation was associated with the activation of NF-κB [1] . Treatment of cultured endothelial cells with pyrrolidine dithiocarbamate, TLCK, genistein or calphostin C, compounds that can block the activation of NF-κB, inhibited the effect of TNF-α on myo-inositol accumulation [1] . TNF-α also activates NF-κB in 3T3-L1 adipocytes ; however, treatment of 3T3-L1 adipocytes with the same compounds, which to differing degrees inhibited the TNF-α-induced activation of NF-κB in 3T3-L1 adipocytes, did not alter the effect of TNF-α on myo-inositol accumulation. Therefore, in addition to the different effect from C ' -ceramide on SMIT mRNA levels and myo-inositol accumulation in cultured endothelial cells and 3T3-L1 adipocytes, the activation of NF-κB by TNF-α in 3T3-L1 adipocytes does not seem to be directly associated with the effect of TNF-α on myo-inositol accumulation, as it was in cultured endothelial cells [1] .
In mammalian cells, hyperosmolarity and TNF-α induce three MAPK pathways : ERK, JNK and p38 kinase [25, 26, 46] . In 3T3-L1 adipocytes, hyperosmolarity induced all three of these kinase pathways to differing degrees, whereas TNF-α had a small effect on JNK activity and no effect on ERK or p38 kinase activity. Inhibitors of ERK or p38 kinase did not block the effect of hyperosmolarity or TNF-α on myo-inositol accumulation. This suggests that in 3T3-L1 adipocytes the effects of hyperosmolarity or TNF-α on SMIT activity are not mediated by ERK or p38 kinase. MAPK activation by osmotic stress is a consistent finding in many mammalian cells, but it is not essential for betaine or myo-inositol transporter gene transcription [47] . In MadinDarby canine kidney cells the p38 kinase inhibitor SB-203580 prevented the osmotic induction of heat-shock protein mRNA [48] . However, SB-203580 did not prevent the hyperosmolarityinduced increase in myo-inositol accumulation in 3T3-L1 adipocytes. This suggests that a cellular difference in the signal transduction pathways mediating the effects of hyperosmolarity, and perhaps TNF-α, might exist.
In summary, our studies have shown that hyperosmolarity and TNF-α have opposing effects on SMIT mRNA levels and myoinositol accumulation in 3T3-L1 adipocytes. The effect of TNF-α on SMIT mRNA levels and myo-inositol accumulation in 3T3-L1 adipocytes and endothelial cells is similar ; however, unlike in endothelial cells, activation of the transcription factor NF-κB by TNF-α in 3T3-L1 adipocytes does not seem to be directly associated with its effects on SMIT activity [1] . The signalling pathways responsible for the effects of hyperosmolarity and TNF-α on SMIT mRNA levels and myo-inositol accumulation in 3T3-L1 adipocytes remain to be elucidated. TNF-α-induced hydrolysis of sphingomyelin does not seem to be necessary for the regulation of SMIT mRNA levels and myo-inositol accumulation in 3T3-L1 adipocytes. In 3T3-L1 adipocytes, but not in endothelial cells, C ' -ceramide did not mimic the effects of TNF-α on SMIT mRNA levels or activity or activate NF-κB. In Jurkat T cells, C # -ceramide mimicked the effects of TNF-α on cell growth but was unable to induce the activation of NF-κB [49] . Thus TNF-α signalling involves multiple second-messenger pathways that function independently or co-ordinately to transduce distinct functions of TNF-α. In 3T3-L1 adipocytes, other signalling pathways activated by TNF-α include the activation of Janus tyrosine kinases (Jak) and the subsequent phosphorylation of members of the STAT family of transcription factors [50] . Further studies will be necessary to determine whether these or other pathways are responsible for mediating the effects of TNF-α on SMIT activity in 3T3-L1 adipocytes.
